Table S3.
Studies | Criteria | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
1* | 2* | 3* | 4* | 5* | 6* | 7* | 8* | 9* | Overall | |
McMullen and McMullen (44) | Y | Y | N | Y | Y | Y | Y | Y | Y | 8/9 88% |
Roy et al. (43) | Y | Y | N | N | Y | U | Y | Y | Y | 6/9 66% |
Yankey and Urmi (42) | Y | Y | Y | Y | Y | Y | Y | Y | Y | 9/9 100% |
Ndetei et al. (45) | Y | Y | Y | N | Y | U | Y | Y | Y | 7/9 77% |
Mohammadi and Poursaberi (40) | Y | Y | U | Y | Y | N | Y | Y | Y | 7/9 77% |
Eslami et al. (41) | Y | Y | Y | Y | Y | Y | Y | Y | Y | 9/9 100% |
McMahon and Hanrahan (46) | Y | Y | Y | Y | Y | Y | Y | U | Y | 8/9 88% |
| ||||||||||
Total | 7/7 100% |
7/7 100% |
4/7 57% |
5/7 71% |
7/7 100% |
4/7 57% |
7/7 100% |
6/7 85% |
7/7 100% |
Notes: JBI methodological quality appraisal checklist to be scored as: Yes = Y; No = N; Unclear = U; Not applicable = NA;
1* Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (i.e. there is no confusion about which variable comes first)?
2* Were the participants included in any comparisons similar?
3* Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest?
4* Was there a control group?
5* Were there multiple measurements of the outcome both pre- and post-intervention/exposure?
6* Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analysed?
7* Were the outcomes of participants included in any comparisons measured in the same way?
8* Were outcomes measured in a reliable way?
9* Was appropriate statistical analysis used?